PMPRB drug pricing changes could delay product launches: survey
The vast majority of pharmaceutical executives said they expect the incoming amendments to the Patented Medicine Prices Review Board to have a negative impact on…
- By: Staff
- February 5, 2020 November 12, 2020
- 15:00
























